Sean Laaman
Stock Analyst at Morgan Stanley
(4.76)
# 618
Out of 5,004 analysts
593
Total ratings
62.5%
Success rate
13.9%
Average return
Main Sectors:
Stocks Rated by Sean Laaman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AXSM Axsome Therapeutics | Rated: Hold | $251 | $195.09 | +28.66% | 11 | Sep 25, 2026 | |
| BMRN BioMarin Pharmaceutical | Rated: Buy | $124 | $60.26 | +105.77% | 11 | Sep 16, 2026 | |
| CGEM Cullinan Therapeutics | Reiterated: Buy | $30 | $14.81 | +102.57% | 11 | Sep 15, 2026 | |
| NBIX Neurocrine Biosciences | Rated: Hold | $182 → $183 | $138.40 | +32.23% | 22 | Sep 11, 2026 | |
| RVMD Revolution Medicines | Initiated Coverage: Buy | $255 | $204.97 | +24.41% | 1 | Sep 10, 2026 | |
| ARGX argenx SE | Rated: Buy | $1,230 → $1,250 | $959.49 | +30.28% | 13 | Sep 1, 2026 | |
| JAZZ Jazz Pharmaceuticals | Rated: Buy | $283 → $322 | $237.95 | +35.32% | 18 | Aug 26, 2026 | |
| ACAD Acadia Pharmaceuticals | Rated: Hold | $27 → $28 | $20.68 | +35.40% | 14 | Aug 25, 2026 | |
| ABSI Absci | Rated: Hold | $10 | $9.74 | +2.67% | 9 | Aug 17, 2026 | |
| ALEC Alector | Rated: Sell | $2 | $1.95 | +2.56% | 6 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $18 | $3.95 | +355.70% | 5 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $93 | $67.15 | +38.50% | 14 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $16 → $18 | $12.58 | +43.08% | 9 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $32 | $7.92 | +304.04% | 2 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $21 | $14.25 | +47.37% | 8 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $22 | $15.15 | +45.21% | 3 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $85 → $90 | $65.24 | +37.95% | 13 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $21 | $10.46 | +100.76% | 7 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $5.5 → $5.3 | $3.74 | +41.71% | 5 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $98 → $97 | $65.57 | +47.93% | 7 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $36 → $40 | $20.39 | +96.17% | 10 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $93 → $105 | $113.90 | -7.81% | 19 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $40 → $43 | $30.72 | +39.97% | 5 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $53 | $58.16 | -8.87% | 20 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $395 → $405 | $360.85 | +12.24% | 12 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $19 → $17 | $28.85 | -41.07% | 4 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.30 | $2.57 | n/a | 19 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $16 | $9.11 | n/a | 1 | Jul 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3.80 → $3.95 | $4.54 | n/a | 22 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $222.00 | n/a | 13 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33.70 | $31.58 | n/a | 16 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $310.00 | $176.95 | n/a | 68 | Jun 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33.60 → $31.65 | $18.79 | n/a | 34 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25.38 → $24.14 | $44.21 | n/a | 18 | Apr 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $26.65 → $28.65 | $45.00 | n/a | 5 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $276.00 → $256.00 | $142.30 | n/a | 21 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $1.30 | $0.38 | n/a | 29 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8.15 → $7.35 | $6.44 | n/a | 21 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.45 → $1.65 | $0.74 | n/a | 15 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48.55 → $47.30 | $19.50 | n/a | 10 | Jan 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $53.60 → $51.60 | $55.31 | n/a | 27 | Nov 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2.70 → $2.75 | $2.21 | n/a | 13 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $13.14 | n/a | 2 | Aug 24, 2021 |
Axsome Therapeutics
Sep 25, 2026
Rated: Hold
Price Target: $251
Current: $195.09
Upside: +28.66%
BioMarin Pharmaceutical
Sep 16, 2026
Rated: Buy
Price Target: $124
Current: $60.26
Upside: +105.77%
Cullinan Therapeutics
Sep 15, 2026
Reiterated: Buy
Price Target: $30
Current: $14.81
Upside: +102.57%
Neurocrine Biosciences
Sep 11, 2026
Rated: Hold
Price Target: $182 → $183
Current: $138.40
Upside: +32.23%
Revolution Medicines
Sep 10, 2026
Initiated Coverage: Buy
Price Target: $255
Current: $204.97
Upside: +24.41%
argenx SE
Sep 1, 2026
Rated: Buy
Price Target: $1,230 → $1,250
Current: $959.49
Upside: +30.28%
Jazz Pharmaceuticals
Aug 26, 2026
Rated: Buy
Price Target: $283 → $322
Current: $237.95
Upside: +35.32%
Acadia Pharmaceuticals
Aug 25, 2026
Rated: Hold
Price Target: $27 → $28
Current: $20.68
Upside: +35.40%
Absci
Aug 17, 2026
Rated: Hold
Price Target: $10
Current: $9.74
Upside: +2.67%
Alector
Aug 17, 2026
Rated: Sell
Price Target: $2
Current: $1.95
Upside: +2.56%
Aug 17, 2026
Rated: Buy
Price Target: $18
Current: $3.95
Upside: +355.70%
Aug 17, 2026
Rated: Buy
Price Target: $93
Current: $67.15
Upside: +38.50%
Aug 17, 2026
Rated: Hold
Price Target: $16 → $18
Current: $12.58
Upside: +43.08%
Aug 17, 2026
Rated: Buy
Price Target: $32
Current: $7.92
Upside: +304.04%
Aug 17, 2026
Rated: Hold
Price Target: $21
Current: $14.25
Upside: +47.37%
Aug 17, 2026
Rated: Buy
Price Target: $22
Current: $15.15
Upside: +45.21%
Aug 17, 2026
Rated: Buy
Price Target: $85 → $90
Current: $65.24
Upside: +37.95%
Aug 17, 2026
Rated: Hold
Price Target: $21
Current: $10.46
Upside: +100.76%
Aug 17, 2026
Rated: Hold
Price Target: $5.5 → $5.3
Current: $3.74
Upside: +41.71%
Aug 11, 2026
Reiterated: Buy
Price Target: $98 → $97
Current: $65.57
Upside: +47.93%
Aug 7, 2026
Rated: Buy
Price Target: $36 → $40
Current: $20.39
Upside: +96.17%
Aug 7, 2026
Rated: Buy
Price Target: $93 → $105
Current: $113.90
Upside: -7.81%
Aug 7, 2026
Reiterated: Hold
Price Target: $40 → $43
Current: $30.72
Upside: +39.97%
Aug 6, 2026
Reiterated: Hold
Price Target: $53
Current: $58.16
Upside: -8.87%
Aug 6, 2026
Reiterated: Buy
Price Target: $395 → $405
Current: $360.85
Upside: +12.24%
May 14, 2026
Reiterated: Hold
Price Target: $19 → $17
Current: $28.85
Upside: -41.07%
Aug 28, 2025
Reiterated: Buy
Price Target: $3.30
Current: $2.57
Upside: n/a
Jul 2, 2025
Initiated Coverage: Hold
Price Target: $16
Current: $9.11
Upside: n/a
Feb 12, 2025
Reiterated: Hold
Price Target: $3.80 → $3.95
Current: $4.54
Upside: n/a
Aug 1, 2024
Rated: Hold
Price Target: n/a
Current: $222.00
Upside: n/a
Jun 24, 2024
Reiterated: Buy
Price Target: $33.70
Current: $31.58
Upside: n/a
Jun 12, 2024
Reiterated: Buy
Price Target: $310.00
Current: $176.95
Upside: n/a
May 22, 2024
Reiterated: Buy
Price Target: $33.60 → $31.65
Current: $18.79
Upside: n/a
Apr 9, 2024
Reiterated: Hold
Price Target: $25.38 → $24.14
Current: $44.21
Upside: n/a
Mar 22, 2024
Reiterated: Hold
Price Target: $26.65 → $28.65
Current: $45.00
Upside: n/a
Mar 21, 2024
Reiterated: Sell
Price Target: $276.00 → $256.00
Current: $142.30
Upside: n/a
Feb 28, 2024
Reiterated: Sell
Price Target: $1.30
Current: $0.38
Upside: n/a
Feb 27, 2024
Reiterated: Hold
Price Target: $8.15 → $7.35
Current: $6.44
Upside: n/a
Feb 26, 2024
Reiterated: Buy
Price Target: $1.45 → $1.65
Current: $0.74
Upside: n/a
Jan 12, 2024
Reiterated: Buy
Price Target: $48.55 → $47.30
Current: $19.50
Upside: n/a
Nov 28, 2023
Reiterated: Hold
Price Target: $53.60 → $51.60
Current: $55.31
Upside: n/a
Aug 28, 2023
Reiterated: Sell
Price Target: $2.70 → $2.75
Current: $2.21
Upside: n/a
Aug 24, 2021
Reiterated: Buy
Price Target: n/a
Current: $13.14
Upside: n/a